Galicaftor
ABBV-2222 is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector investigated for the treatment of cystic fibrosis. It is utilized in research to study CFTR protein rescue and function in both cellular models and in vivo preclinical studies.
Product Specifications
CAS Number
1918143-53-9
Field of Research
Pharmacology & Drug Discovery
Purity
98.84% (May vary between batches)
Smiles
C (N[C@H]1C=2C (O[C@H] (C1) C3=CC=C (C (O) =O) C=C3) =CC (OC (F) F) =CC2) (=O) C4 (CC4) C=5C=C6C (=CC5) OC (F) (F) O6
Molecular Formula
C28H21F4NO7
Molecular Weight
559.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7009661-01 0.02 mg
Recombinant Lactobacillus johnsonii ATP synthase subunit b (atpF)
Sign In for Pricing
View Details 
MBS7009661-02 0.1 mg
Recombinant Lactobacillus johnsonii ATP synthase subunit b (atpF)
Sign In for Pricing
View Details MBS7009661-03 5x 0.1 mg
Recombinant Lactobacillus johnsonii ATP synthase subunit b (atpF)
Sign In for Pricing
View Details 